Forcyte Biotechnologies

Forcyte Biotechnologies is a drug discovery company in Los Angeles, United States, founded in 2017. It has raised $2.4M across 5 rounds, most recently a Seed in June 2022.

Discover drugs that control how much cells "squeeze" to treat disease

Employees
1–10
Founded
2017
Total Funding
$2.4M
Last Round
SeedJun 2022
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 4 investors for this company. The full record is or through the API.

About

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

Summary

It lists 1–10 employees. It has raised $2.4M in total across 5 rounds, most recently a Seed round in Jun 2022. Investors include Y Combinator, Pioneer Fund and Acequia Capital.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundJun 2022

Sign up to see all 5 events

Funding: Grant through Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Forcyte Biotechnologies on Indexed.vc
<a href="https://indexed.vc/companies/forcyte-biotechnologies-inc"><img src="https://indexed.vc/api/badge/company/forcyte-biotechnologies-inc" alt="Forcyte Biotechnologies on Indexed.vc" width="260" height="76" /></a>